Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
Ciampi R; Knauf JA; Kerler R; Gandhi M; Zhu Z; Nikiforova MN; Rabes HM; Fagin JA; Nikiforov YE; The Journal Of Clinical Investigation, 2005, vol. 115, issue 1, p 94, ISSN 00219738. ISBN 00219738.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef